Frontlight ResearchEarly access
Trial site
California Institute of Renal Research
- 2running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease4 trials
- Coronary artery disease1 trial
- Lupus (SLE)1 trial
- Peripheral artery disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 31 trial
- Status
- Completed3 trials
- Recruiting2 trials
- Suspended1 trial
- Lead sponsor
- Anji Pharma1 trial
- Biocon Limited1 trial
- CSL Behring1 trial
- Palatin Technologies, Inc1 trial
- R1 Therapeutics1 trial
- and 1 more
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Coronary artery disease1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Completed
Completed
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026